The Narrowing Path for Nilotinib and Other Potential Disease-Modifying Therapies for Parkinson Disease-Reference-Cited by-同舟云学术

The Narrowing Path for Nilotinib and Other Potential Disease-Modifying Therapies for Parkinson Disease

Published:2020-03-01 Issue:3 Volume:77 Page:295
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Espay Alberto J.¹,Hauser Robert A.²,Armstrong Melissa J.³

Affiliation:

1. James J. and Joan A. Gardner Family Center for Parkinson’s Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, Ohio

2. Department of Neurology, University of South Florida, Tampa

3. Department of Neurology, University of Florida College of Medicine, Gainesville

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Link

https://jamanetwork.com/journals/jamaneurology/articlepdf/2757498/jamaneurology_espay_2019_ed_190027.pdf

Reference6 articles.

1. Nilotinib effects in Parkinson’s disease and dementia with Lewy bodies.;Pagan;J Parkinsons Dis,2016

2. Nilotinib—differentiating the hope from the hype.;Wyse;J Parkinsons Dis,2016

3. Nilotinib effects on safety, tolerability, and potential biomarkers in Parkinson disease: a phase 2 randomized clinical trial;Pagan;JAMA Neurol

4. Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.;Espay;Neurology,2019

5. Precision medicine for disease modification in Parkinson disease.;Espay;Nat Rev Neurol,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lewy Body Dementia: An Overview of Promising Therapeutics;Current Neurology and Neuroscience Reports;2023-08-12

2. Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy;Pharmaceutics;2023-07-30

3. Discovery of 4-methyl-3-(pyridin-2-ylamino)benzamide derivatives as C-Abl inhibitors with potential neuroprotective effect;Bioorganic & Medicinal Chemistry;2022-11

4. Drug reprofiling history and potential therapies against Parkinson’s disease;Frontiers in Pharmacology;2022-10-26

5. Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection;Pharmacological Reviews;2021-10